GOVERNMENT OF INDIA logoGOVERNMENT OF INDIA
Skip to main content
Accessibility
Accessibility Tools
Color Adjustment
Text Size
Navigation Adjustment
Screen Reader iconScreen Reader

Drug Discovery Hackathon 2020 (DDH2020)

Phase 1
Submission
30 November 2020

Problem Statements

Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-01

Develop a reinforcement learning-based algorithm to identify lead molecules by emulating ligand-protein interactions

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-02

Machine learning models to prioritize optimal parameters of predicted ADME and Toxicity data

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-03

Building SARS-CoV-2 Inhibitor Knowledgebase – SAVIOR

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-04

Machine intelligence design and development of main protease inhibitors drugs.

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-05

To develop a regression based QSPR model for Caco-2 cell permeability.

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-06

Predicting the biological properties of potential SARS-CoV-2 inhibitors using graph theory and machine learning

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-07

ML model to predict small molecule clinical trial success probability by phase

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-08

Matched Pair Analysis based tool to generate isosteric and bioisosteric molecular libraries

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-09

Automated Analogue library generation tool using bioisosteres

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-10

ML model for antiviral peptide predictions using Generative Adversarial Networks

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-11

Implement a framework to mine protein-ligand & protein-protein interaction networks for drug repurposing

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-12

To improve the efficiency of MOLS algorithm in terms of sampling, scoring and computational time

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-13

Developing a linear discriminant analysis model for screening pharmaceutical compounds with hERG inhibitory activity (cardiotoxicity) and using the model to screen CAS antiviral database to identify compounds with cardiotoxicity potential

View Details
Category : T2 - General Drug Discovery, Including COVID PS ID : DDT2-14

A computational pipeline to predict Drug Induced Liver Injury (DILI).

View Details